Information Density: LivaNova PLC – Signal Evidence & AI Readability

LivaNova PLC

(https://livanova.com) 📸 Data Snapshot: May 30, 2026
Information Density — The Lens

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Info Density Power-words vs. Substance ratio.
22 Impact Weight: 30 / 100
73% Reputation

The site displays a bifurcated density profile: the homepage leans into marketing power words like ingenious, ignite, and transformative, while the sub-pages deliver high-substance forensic evidence. For example, the Compliance page moves beyond fluff to cite specific California Health and Safety Codes and 24/7 Ethics Helpline protocols. Specificity is high regarding history (25+ years in VNS Therapy, 50+ in Cardiopulmonary) and scale (3,000+ employees). However, H1 and H2 tags on the homepage like Welcome to impact & innovation and Create new beginnings are pure signal-to-noise failures.

Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.

📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://livanova.com) Neuromodulation and Cardiopulmonary Medical Devices | LivaNova
[H1] Welcome to impact & innovation

At LivaNova, we are working to change the trajectory of lives.

Learn More

[H2] Ingenious Medical Solutions That Ignite Patient Turnarounds

At LivaNova, we don’t just treat conditions — we aspire to alter the course of lives, striving to offer days without seizures, nights of unencumbered sleep, minds unburdened by depression, hearts beating strong and steady. *Availability of products and product information varies by geography.

[IMG: Essenz Perfusion System]

[H4] Essenz™ Perfusion System

Visit Website

[IMG: Sentiva device, wand, and app]

[H4] VNS Therapy™ for Epilepsy

Visit Website

[IMG: Symmetry device]

[H4] VNS Therapy™ for Depression

Visit Website

[IMG: Welcome to a New Day video thumbnail]

[H2] Welcome to a New Day

We see the person beyond the condition, the potential beyond the limitations, the life waiting to be reclaimed.

About Us

[H2] Supporting Well-Being with a Sustainable Business

We work to reduce the environmental impact of our products and operations, provide engaging and rewarding work for our employees, and always lead with product safety.
Learn More

[IMG: LivaNova employee]

[H6] Create new beginnings

[H2] LivaNova Careers

We treat our work as if lives depend on it — because they do. As a people-oriented company, our employees around the world are fully committed to making the world a better place.

Join Us
1856 chars
SUB-PAGE (https://livanova.com/en-us/about-us/compliance/) LivaNova Compliance | LivaNova
[H1] Compliance

[H4] LivaNova operates within a framework of principles, guidelines and policies aligned with ethical, social and environmental responsibilities, and we abide by the highest standards of business ethics and compliance. We are guided by our Code of Ethics and Business Conduct (also referred to as “Code of Conduct”) that applies to all employees and board directors of LivaNova and its subsidiaries, and sets the tone for our global ethics and compliance program.

[H2] Compliance

Global Compliance Program

Anti-Harassment/Discrimination

Speak Up

Third Party Code

Modern Slavery

Conflict Minerals

Industry Affiliations

Transparency in Italy

At LivaNova, we are committed to maintaining an effective and comprehensive compliance program. As a manufacturer of medical devices, LivaNova has designed a Global Compliance Program to comply with all applicable laws, regulations and industry codes related to the ethical and compliant promotion and sales of our products in the countries where we operate.

The LivaNova Code of Ethics and Business Conduct, Third Party Code of Conduct, and various other company policies and procedures are made available in multiple languages to internal users and, where applicable, to external ones to ensure awareness and understanding of the Company’s ethical standards and expectations. Applicable personnel and third parties receive training on the Codes and the policies that apply to them.

Underpinning and surrounding LivaNova’s Compliance Program is an intricate yet dynamic web of risk-assessment, monitoring, and auditing activities. In order to effectively maintain such a sophisticated program, leadership engagement at all levels is of the essence. LivaNova is fortunate to have strong support and “tone from the top” from all levels of leadership in support of our compliant business practices.

Overall oversight of LivaNova’s Global Compliance Program lies ultimately with the Chief Compliance Officer and the Audit and Compliance Committee of the LivaNova Board of Directors.

To its knowledge, LivaNova is in all material respects in compliance with the California Health and Safety Code, §§ 119400 – 119402. Further information can be found here.

At LivaNova we seek to unite people. We value diversity and offer the same welcome to all employees and partners regardless of race, gender, nationality, ethnic origin, religion, age or sexual orientation. Everyone should be treated with dignity and respect. Bullying, intimidation or harassment of any kind is not acceptable in our workplace.

[H3] Documents

Title
View

Global Anti-Harassment and Anti-Discrimination Policy

[IMG: Global Anti-Harassment and Anti-Discrimination Policy]

Gender Equality Index France/Index Égalité Femmes-Hommes France

[IMG: Gender Equality Index France/Index Égalité Femmes-Hommes France]

At LivaNova, fostering an ethical culture is very important. Raising concerns not only protects our company but also our customers, patients, and each other. By being open and candid about our concerns, we set an example for others to Speak Up, creating a safe environment for everyone.

If you suspect a violation of the Code of Ethics & Business Conduct, our policies, or the law, you have an obligation to promptly raise a concern. When in doubt, always Speak Up.

Our Speak Up Program includes a 24/7 Ethics Helpline, available to employees and third parties for confidential and anonymous reporting via web, email, or phone, in multiple languages.

All leaders must ensure a safe space for employees to raise concerns without fear of retaliation. Any concerns about potential violations should be immediately escalated to the Ethics Helpline, Compliance, or Human Resources.

As described in both our Code of Conduct and Speak Up and Non-Retaliation Policy, everyone at LivaNova has a responsibility to promptly report any violation of the Company’s Code of Conduct, Policies, Procedures, laws impacting Company business, or any other potentially unethical conduct to Compliance, or report confidently at https://livanova.ethicspoint.com.

Once a report is received, the Head of Global Investigations (or their delegate) classifies, triages, and assigns the report to an investigator for investigation.  Ethics Helpline metrics and Critical cases are reported quarterly by the Chief Compliance Officer to the Compliance Committee and to the Audit Committee of the LivaNova Board of Directors.

LivaNova has a strict non-retaliation policy and does not tolerate any form of retaliation against individuals who, in good faith, report potential violations or participate in investigations. Whistleblower rights and remedies are protected under applicable laws. This policy applies even if an allegation made in good faith is ultimately unsubstantiated.

For German / Italian employees, please refer to local Speak Up policies for more information.

[H3] Our Global Speak Up and Non-Retaliation Policy

Title
View

Arabic

[IMG: Arabic]

Chinese

[IMG: Chinese]

English

[IMG: English]

French

[IMG: French]

German

[IMG: German]

Italian

[IMG: Italian]

Japanese

[IMG: Japanese]

Portuguese

[IMG: Portuguese]

Spanish

[IMG: Spanish]

Thai

[IMG: Thai]

[H2] Options to Speak Up

[IMG: phone icon]

[H4] Phone

1-833-208-4076
The LivaNova Ethics Helpline is a toll-free telephone line managed by a third-party provider. If requested and allowable by local law, reporters will be granted full anonymity. The hotline is available globally and in multiple languages. Additional local numbers can be found here

[IMG: computer icon]

[H4] Web

https://livanova.ethicspoint.com
The LivaNova Ethics Helpline can also be reached via web through our third-party managed, confidential and anonymous (if requested and allowable by local law) online reporting tool.

[IMG: email icon]

[H4] Email

[email protected]
The LivaNova Ethics Inbox is managed by Corporate Compliance and any concerns received will remain confidential.

LivaNova embraces the key principles of the International Labour Organization’s fundamental conventions. We believe that our business can only succeed where the rights of all workers involved in the value chain of our business are protected and respected, and we aim to conduct business with suppliers, distributors, agents, product resellers, vendors, consultants, contingent workers, and other business partners (“Third Parties”) who share our commitment to operating in a responsible and ethical manner.

Accordingly, this Third Party Code of Conduct outlines the standards and expectations for ethical and sustainable business conduct of LivaNova Third Parties, and their subsidiaries, subcontractors, affiliates, employees, and agents (“Representatives”). It covers areas such as human rights and labor conditions, the environment, quality, and confidentiality and data privacy.

[H3] Third Party Code of Ethics and Business Conduct

Title
View

Arabic

[IMG: Arabic]

Chinese

[IMG: Chinese]

English

[IMG: English]

French

[IMG: French]

German

[IMG: German]

Italian

[IMG: Italian]

Japanese

[IMG: Japanese]

Korean

[IMG: Korean]

Portuguese

[IMG: Portuguese]

Russian

[IMG: Russian]

Spanish

[IMG: Spanish]

Thai

[IMG: Thai]

LivaNova is fully committed to maintaining the highest standards of ethical conduct and regulatory compliance with laws and regulations across all aspects of our business, including laws related to slavery and human trafficking. The most recent statement sets out the Company's efforts towards this commitment for the fiscal year starting 1 January 2025 and ending 31 December 2025.As part of our commitment to identify and mitigate risks relating to modern slavery and human trafficking in LivaNova’s operations or in the operations throughout our supply chain, LivaNova has taken the steps described further in this statement and is committed to identifying areas for improvement in its approach to preventing modern slavery and human trafficking and related policies and practices.

[H3] Modern Slavery Statements

Title
View

2025 Modern Slavery and Human Trafficking Statement

[IMG: 2025 Modern Slavery and Human Trafficking Statement]

2024 Modern Slavery and Human Trafficking Statement Archived

[IMG: 2024 Modern Slavery and Human Trafficking Statement Archived]

2023 Modern Slavery and Human Trafficking Statement Archived

[IMG: 2023 Modern Slavery and Human Trafficking Statement Archived]

2022 Modern Slavery and Human Trafficking Statement Archived

[IMG: 2022 Modern Slavery and Human Trafficking Statement Archived]

2021 Modern Slavery and Human Trafficking Statement Archived

[IMG: 2021 Modern Slavery and Human Trafficking Statement Archived]

2020 Modern Slavery and Human Trafficking Statement Archived

[IMG: 2020 Modern Slavery and Human Trafficking Statement Archived]

2019 Modern Slavery and Human Trafficking Statement Archived

[IMG: 2019 Modern Slavery and Human Trafficking Statement Archived]

We are committed to ensuring that our supply chain reflects our values and beliefs, including adherence to principles of responsible sourcing for materials for our products. As part of our commitment, LivaNova supports the goals and objectives of Section 1502 of the Dodd-Frank Act, which focuses on supply chain transparency through the identification and disclosure of potential risks related to sourcing of conflict minerals. We conduct annual due diligence to identify and assess possible concerns within our supply chain and transparently report our findings. We expect our suppliers to support our efforts to comply with the Dodd-Frank Act and to proactively identify and work towards preventing the use of any minerals that fund or benefit armed groups from within our supply chain.

[H3] Conflict Minerals Report

Title
View

Conflict Minerals Report

[IMG: Conflict Minerals Report]

To help navigate the complex compliance environment in which we operate, LivaNova has adopted the AdvaMed Code of Ethics on Interactions with Health Care Professionals, the APACmed Code of Ethical Conduct , the Mecomed Code of Ethical Business Practice and the MedTech Europe Code of Ethical Business Practice.

These industry guidelines, along with the LivaNova Code of Conduct and ethics & compliance policies, are the foundation of LivaNova's ethics and compliance program.

[H3] Industry Guidelines

Title
View

AdvaMed China Code of Ethics

[IMG: AdvaMed China Code of Ethics]

AdvaMed India Code of Ethics

[IMG: AdvaMed India Code of Ethics]

AdvaMed US Code of Ethics

[IMG: AdvaMed US Code of Ethics]

Mecomed Code of Ethical Business Practice

[IMG: Mecomed Code of Ethical Business Practice]

MedTech Europe Code of Ethical Business Practice

[IMG: MedTech Europe Code of Ethical Business Practice]

At LivaNova, our priority is to improve the lives of patients with our products and therapies. Without the help of our valued partners in the healthcare field, we would not be able to achieve this goal.

To build and maintain trust between the medical device industry, the healthcare players, and patients, we strive to continuously operate with quality and integrity in everything we do. This includes also complying with laws and rules regulating our interactions with healthcare professionals and organizations. In this regard, LivaNova follows all applicable transparency requirements within the jurisdictions we operate.

Confindustria Dispositivi Medici, an Italian medical association, requests that its members document and publish all direct and indirect transfers of value to healthcare professionals, healthcare organizations and third parties.

When necessary, a consent to process and publish personal data is to be provided by the healthcare entities. In the event the consent is not given, the data is published on an aggregated basis.

LivaNova shall publish the transfers of value made each year within the first six months of the following year.

For more information about the LivaNova Transparency Program, please email [email protected].

[H3] Transparency Reports

Title
View

2024 Transparency Report - Italy

[IMG: 2024 Transparency Report - Italy]

2024 Methodology Note

[IMG: 2024 Methodology Note]

2023 Transparency Report - Italy

[IMG: 2023 Transparency Report - Italy]

2023 Methodology Note

[IMG: 2
15000 chars
SUB-PAGE (https://livanova.com/en-us/about-us/) About LivaNova, a Global Medtech Company | LivaNova
[H1] About LivaNova

A global medtech company
At LivaNova, we don’t just treat conditions — we aspire to alter the course of lives through ingenious medical solutions.

[IMG: A woman doctor gazing out]

[H2] Welcome to Your New Life

At LivaNova, we see the patient beyond the condition. The potential beyond the limitations. The life waiting to be reclaimed. Welcome to our product portfolio:Cardiopulmonary | Difficult-to-Treat Depression | Drug-Resistant Epilepsy

[H2] Built on Decades of Experience

LivaNova is a global medical technology company built on decades of experience and a relentless commitment to patients. Our products and therapies are used worldwide.

25+

years of experience with VNS Therapy™

50+

years of proven cardiopulmonary innovation

[H2] Inspired People

Our more than 3,000 talented team members turn bold ideas into life-changing medtech solutions that transform lives for people across the world.

[IMG: collage of 5 employees faces]

[H4] Who We Are

Welcome to LivaNova

[IMG: lobby of Munich facility]

[H4] Transformative Leaders

Meet our leadership team

[IMG: collage of people working medtech jobs]

[H4] Innovative Teams

Meet women in medtech

[H4] Impactful Careers

Find your next job

Swipe or use arrows to explore

[H2] Guided by Ethics & Experience

Our commitment to patients and those who care for them dedicates us to high quality and integrity in everything we do. It compels us to operate at the topmost level of business ethics, guided by leaders with deep experience.
Learn More
2010 chars
SUB-PAGE (https://livanova.com/en-us/contact-us/) LivaNova Customer Service & Other Contacts | LivaNova
[H1] Contact Us

[H2] Customer Service Contacts

Choose your country to find customer service contact information. For other inquiries, fill out the form below.

Location

[IMG: woman looking through a microscope]

[H4] Investigator-Initiated Research

Our mission to advance the quality of life for patients resonates through each investigator-initiate research project we support.
Learn More

[IMG: Scientist working in a lab]

[H4] Donations and Grants

We support educational and charitable endeavors that benefit health and society and demonstrate good corporate citizenship.
Collaborate With Us

[IMG: People walking in a building]

[H4] Commercial Sponsorships

We will consider commercial sponsorships for events that are relevant to LivaNova's therapeutic areas.
Make a Request

[H4] Medical Affairs

Find published scientific and clinical information about our therapies intended as scientific exchange and for healthcare professionals only.
Visit Site
1293 chars
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes, pioneering medical science, the future of medicine…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified, patient testimonials making efficacy claims, off-label promotion signals…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations, specific patent numbers and status, pharmacovigilance and adverse event reporting mechanisms…